O

Optus Pharmaceutical Co Ltd
KOSDAQ:131030

Watchlist Manager
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Watchlist
Price: 6 930 KRW Market Closed
Market Cap: 122.3B KRW

Intrinsic Value

The intrinsic value of one Optus Pharmaceutical Co Ltd stock under the Base Case scenario is 6 771.14 KRW. Compared to the current market price of 6 930 KRW, Optus Pharmaceutical Co Ltd is Overvalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
6 771.14 KRW
Overvaluation 2%
Intrinsic Value
Price
O
Worst Case
Base Case
Best Case

Valuation History
Optus Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Optus Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Optus Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Optus Pharmaceutical Co Ltd.

Explain Valuation
Compare Optus Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Optus Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Optus Pharmaceutical Co Ltd

Current Assets 74.9B
Cash & Short-Term Investments 39.5B
Receivables 11.6B
Other Current Assets 23.8B
Non-Current Assets 96.9B
Long-Term Investments 11.8B
PP&E 67.9B
Intangibles 15.9B
Other Non-Current Assets 1.4B
Current Liabilities 23B
Accounts Payable 2.7B
Accrued Liabilities 7.1B
Other Current Liabilities 13.2B
Non-Current Liabilities 1.5B
Long-Term Debt 593.2m
Other Non-Current Liabilities 900.2m
Efficiency

Free Cash Flow Analysis
Optus Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Optus Pharmaceutical Co Ltd

Revenue
82.8B KRW
Cost of Revenue
-36.6B KRW
Gross Profit
46.2B KRW
Operating Expenses
-37.9B KRW
Operating Income
8.3B KRW
Other Expenses
1.2B KRW
Net Income
9.5B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Optus Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Net Margin
Healthy Net Margin
50/100
Profitability
Score

Optus Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Optus Pharmaceutical Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Long-Term Solvency
Negative Net Debt
Low D/E
95/100
Solvency
Score

Optus Pharmaceutical Co Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Optus Pharmaceutical Co Ltd

There are no price targets for Optus Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Optus Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Optus Pharmaceutical Co Ltd stock?

The intrinsic value of one Optus Pharmaceutical Co Ltd stock under the Base Case scenario is 6 771.14 KRW.

Is Optus Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 6 930 KRW, Optus Pharmaceutical Co Ltd is Overvalued by 2%.

Back to Top